Sign up to save your podcasts
Or
Share SHANTIVAX - INTERVIEW WITH GENLAB'S CHIEF EXEC KAMSELLIN CHETTY
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
SHANTIVAX - INTERVIEW WITH GENLAB'S CHIEF EXEC KAMSELLIN CHETTY
#COVID19 #CHOOSELIFE
South African company, GENLAB, has joined forces with Danish company, Immunitrack, to design and develop the first vaccine of African origin against COVID-19, called Shantivax. We chat to Genlab Chief Exec Kamsellin Chetty to find out more
South African company, GENLAB, has joined forces with Danish company, Immunitrack, to design and develop the first vaccine of African origin against COVID-19, called Shantivax. We chat to Genlab Chief Exec Kamsellin Chetty to find out more
View all episodes
By Lotus FM#COVID19 #CHOOSELIFE
South African company, GENLAB, has joined forces with Danish company, Immunitrack, to design and develop the first vaccine of African origin against COVID-19, called Shantivax. We chat to Genlab Chief Exec Kamsellin Chetty to find out more
South African company, GENLAB, has joined forces with Danish company, Immunitrack, to design and develop the first vaccine of African origin against COVID-19, called Shantivax. We chat to Genlab Chief Exec Kamsellin Chetty to find out more